// App-Quantinova.ai

P625 : Use of infliximab (Remicade ) for IBD within a patient support program: Positive perception of i.v. infusions from patien-s perspective

Researchers

Presenter

  • Dajnowiec Dorota

Principal Investigators

  • Jones Jennifer

  • Borgaonkar Mark

  • iffledeen Jesse

  • Williamson Martin

  • Dyrda Peter

Medical Centers

  • Janssen Canada, Market Access, Toronto, Canada

  • Janssen Canada, Medical Affairs, Toronto, CanadaUniversity of Alberta, Gastroenterology, Edmonton, CanadaDalhousie University, QE II Health Sciences Center, Gastroenterology, Halifax, Canada

  • Memorial University, Gastroenterology, St. John's, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Regenerating islet-derived 1 alpha

Drug/Treatment

  • Infliximab

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved